Alco Therapeutics Company Profile, Contacts & Intelligence

Alco Therapeutics Overview

Alco Therapeutics is a virtual pharmaceutical company dedicated to developing innovative treatments for neurobehavioral disorders, including Obsessive-Compulsive Disorder (OCD), Tourette's Syndrome, and Amyotrophic Lateral Sclerosis (ALS), by repurposing an existing, safe drug through our patent-pending treatment method. Problem: The current standard of care for OCD is limited by low efficacy and costly side effects, which leads a high percentage of patients to go untreated. As a result, patients face a high burden of disease and significantly diminished quality of life, creating an urgent demand for better therapeutic options. There have been no new approved treatments for OCD in more than twenty years. Solution: Alco Therapeutics is developing a proprietary treatment method based on histamine signaling pathways. Our approach has the potential to reduce OCD symptoms, enhancing the quality of life of patients and increasing their productivity and reducing comorbidities, disability and suicide rates. Due to positive anecdotal evidence and promising previous preclinical trial data, we believe our treatment can revolutionize the management of OCD and significantly improve patient outcomes.

Headquarters

Boston, Ma, United States

Website

alco.bio

Industry

Pharmaceutical Manufacturing

Founded

2023

NAICS

Pharmaceutical and Medicine Manufacturing, Medicinal and Botanical Manufacturing

Compare Similar Companies to Alco Therapeutics

Explore companies in related markets and compare their industry and employee estimates.